Kramann, R. (2018). The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis. American Society of Hematology (ASH).
Chicago Style (17th ed.) CitationKramann, R. The Identification of Fibrosis-driving Myofibroblast Precursors Reveals New Therapeutic Avenues in Myelofibrosis. American Society of Hematology (ASH), 2018.
MLA (9th ed.) CitationKramann, R. The Identification of Fibrosis-driving Myofibroblast Precursors Reveals New Therapeutic Avenues in Myelofibrosis. American Society of Hematology (ASH), 2018.
Warning: These citations may not always be 100% accurate.